Search results
FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma
Medscape· 5 days agoThe US Food and Drug Administration (FDA) has announced the withdrawal of its 2021 accelerated approval of infigratinib (Truseltiq) for patients with a certain type of previously ...
Larimar Therapeutics Shares Up 22%, FDA Lifts Hold for Nervous System Disorder Treatment
Morningstar· 6 days agoShares of Larimar Therapeutics were trading higher in after-hours action Monday, following news the U.S. Food and Drug Administration has lifted a partial clinical hold on ...
...: Kessler Topaz Meltzer & Check, LLP Reminds Akero Therapeutics, Inc. Shareholders of Deadline in...
WTRF Wheeling· 4 days ago("Akero") (NASDAQ: AKRO). As a result of Akero's materially misleading statements and omissions to the public, Akero's investors have suffered significant losses.
ADDF invests $5 million in Coya Therapeutics for FTD treatment By Investing.com
Investing.com· 6 days agoCoya Therapeutics, Inc. (NASDAQ:COYA), a biotech firm focusing on regulatory T cell therapies, has...
Cleveland company gets FDA greenlight for foot ulcer treatment trial
Crain's Cleveland Business· 4 days agoDiscovery Therapeutics Caribe is targeting mid-2028 to start marketing the product, provided the trial is successful and the company receives the necessary approvals to move ...
FDA seeks AI tech to predict, detect Parkinson’s symptoms
Healthcare Dive· 5 days agoFreezing of gait is a temporary loss of forward movement while walking. By testing these models against its own data, the FDA hopes to better understand the ability of these ...
Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement - Kazia ...
Benzinga· 3 days agoKazia Therapeutics Limited KZIA (Kazia or the company) received a letter on May 22, 2024 from Nasdaq notifying the Company that, while the Company has not regained compliance ...
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks· 3 days agoFree Report) announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its lead pipeline candidate, Descartes-08, for the treatment ...
CKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud Lawsuit
WTNH-TV New Haven· 2 days agoLaw Offices of Howard G. Smith announces that investors with substantial losses have opportunity to...
XPeng Posts Strong Results, Joins Larimar Therapeutics, Transcat And Other Big Stocks Moving Higher...
Benzinga· 5 days agoHere are some other big stocks recording gains in today's session. Waldencast plc WALD shares...